It is a food and beverages private limited company based in New Delhi, Delhi, India, established in 2010.
2010 | New Delhi, Delhi, India | ActiveGum Pharma Private Limited, a active private limited company, was established on 05 January 2010 in New Delhi, Delhi, India. Engaging in bakery & confectionery products within the manufacturing sector, it holds CIN: U24232DL2010PTC197641. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.97 Cr.
It upholds a compliant status. Its leadership includes Madhav Gupta (Nominee Director), Sanjiv Kumar (Director). Past directors included Virender Sehgal, Carsten Krog, Holger Bagger Sorensen. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 201, Harsh Bhawan 64-65, Nehru Place, New Delhi, Delhi, 110019.
U24232DL2010PTC197641
197641
05 January 2010
₹6.00 Cr
₹5.97 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Gum Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhav Gupta | Nominee Director | 08 Apr 2010 | Current |
| Sanjiv Kumar | Director | 08 Apr 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Nominee Director | 30 Mar 2011 | Past |
| Pramod Abcsdd | Nominee Director | 13 Apr 2016 | Past |
| Pramod Abcsdd | Nominee Director | 13 Apr 2016 | Past |
| Pramod Abcsdd | Director | 08 Apr 2010 | Past |
| Pramod Abcsdd | Nominee Director | 12 Apr 2016 | Past |
| Pramod Abcsdd | Key Managerial Personnel | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gum Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.62% increase. The company also saw a substantial improvement in profitability, with a 21.35% increase in profit. The company's net worth Soared by an impressive increase of 11.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Gum Pharma had a promoter holding of 83.74% and a public holding of 16.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Gum Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gum Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gum Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Gum Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Gum Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Madhav Gupta was appointed as a Nominee Director was appointed as a Nominee Director on 08 Apr 2010 & has been associated with this company since 15 years 7 months . was completed.
The activity Sanjiv Kumar was appointed as a Director was appointed as a Director on 08 Apr 2010 & has been associated with this company since 15 years 7 months . was completed.
The activity Gum Pharma Private Limited was registered on 05 Jan 2010 with Roc Delhi & aged 15 years 10 months as per MCA records. was completed.
The CIN of Gum Pharma Private Limited is U24232DL2010PTC197641.
Gum Pharma Private Limited is headquartered at 201, Harsh Bhawan 64-65, Nehru Place, New Delhi, Delhi, 110019.
Gum Pharma Private Limited was incorporated on 05 January 2010.
The current directors of Gum Pharma Private Limited are
The primary industry of Gum Pharma Private Limited is Manufacturing.
Gum Pharma Private Limited is unlisted.
The authorized capital of Gum Pharma Private Limited is ₹6.00 Cr, and the paid-up capital is ₹5.97 Cr.
The compliance status of Gum Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX